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Inflammatory Bowel Disease (IBD) is one of the most rapidly growing chronic diseases 
worldwide. Although the exact cause of the disease is still unknown some epidemiological studies 
suggest that factors related to diet might exacerbate the signs and symptoms of the disease. The 
value of a multidisciplinary approach, combined with dietary counseling, has been well 
documented across literature in various chronic disease management, and could be further adapted 
in the care of IBD patients. My problem of practice is that the gastroenterology practitioners at the 
Digestive Disorder Center (DDC) at UPMC underutilize nutritional services to manage the 
symptomology of the disease. Currently, our gastroenterology clinics operate without the use of 
dietary services to care for Crohn’s and ulcerative colitis patients; both patients and practitioners 
could greatly benefit from the use of nutritional services at the DDC.     In this inquiry, I sought to 
investigate if educating gastroenterology fellows about the role of diet in IBD management would 
increase nutrition knowledge and the referral rate to nutritional counseling. My proposed 
intervention was to design and implement a brief online education module on the role of diet in 
the management of IBD for gastroenterology fellows. In Phase I, fellows completed a baseline 
survey assessing their knowledge of IBD diets and nutritional services at the DDC, and current 
referral practices. In Phase II, they participated in the online education module. In Phase III, I 
assessed their knowledge immediately post-module and in Phase IV, their behavior (i.e., referral 
rates and conversations with patients) 30 days  later. Analysis comparing the pre- and post-
v 
intervention responses revealed that there was significant intervention effect in participants’ 
familiarity of patient dietary services at DDC, knowledge of natural diet modalities in IBD; change 
in participants’ frequency of talking to patients about natural diet modalities were borderline 
significant. The education module was easy to implement online, low cost, and fellows reported 
high levels of learning and intentions to refer patients. Based on these findings, I recommend this 
training be integrated into the fellows’ standard training curriculum. Future PDSA cycles should 
consider feedback from the fellows to strengthen the module, include a longer follow up period, 
and more interaction/prompts for fellows after the training.   
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This dissertation presents the research, findings and recommendations to inspire and 
influence the gastroenterology physician- patient dialog of tomorrow to identify the clinical 
trajectories in treatment response. Driven by this conviction, I could not have achieved my 
current level of success without support from my expert committee.  I hope this unique project 
will create a new path for healthcare professionals and researchers, and lead to interesting 
discoveries and advances.  Secondly, my beautiful and talented daughter Natalie. You are my 
world. You paid the biggest price when I was too busy thinking about work to play with you. 
Thank you for being my anchor in this sea of life.   I hope I made you proud.
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1.0 Naming and Framing the Problem of Practice 
1.1 Broader Problem Area 
1.1.1 Etiology of Inflammatory Bowel Disease  
Inflammatory Bowel Disease (IBD) is growing globally and it has quickly become one of 
the most rapidly increasing diseases worldwide (M’Koma et al., 2013). IBD is a condition 
characterized by chronic inflammation of the gastrointestinal tract and is an umbrella term used 
for two conditions: Crohn’s disease and ulcerative colitis (Crohn’s & Colitis Foundation, 2014).  
Signs and symptoms that are characteristic of both diseases include persistent diarrhea, abdominal 
pain and cramping, bloody stools, and unintended weight loss. An estimated 70,000 new cases of 
IBD are diagnosed in the United States each year and as many as 1.6% (3.5 million) Americans 
are said to have IBD. Both conditions are chronic and often begin in young adults. Although the 
exact cause of the disease is still unknown, epidemiological studies suggest that the disease is 
triggered by a combination of immune system responses, genetics, and a number of external 
environmental agents (Yeshi et al., 2020).  Factors such as low fiber, high animal fat, and high 
sugar diets may affect the short chain fatty acid production and the microbiota of the gut, thereby 
suggesting that dysbiosis is a contributing factor in the increasing incidence of IBD (Gill et al., 
2018). Broadly defined, dysbiosis is a disruption of the microbial ecology or microbial imbalance 
of the gut, “good” vs. “bad” bacteria used in digestion. This loss of diversity of microbial species 
has been linked to immunity and certain diseases, such as IBD (Petersen et al., 2014).  
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1.1.2 Current Treatments and Therapies for Inflammatory Bowel Disease 
There is no cure for IBD and currently available and common treatment options are usually 
limited to pharmacological and surgical management. The relapsing nature of the disease requires 
chronic treatment and often leads to substantial medical interventions and massive cost to the 
patient and the healthcare system (Yeshi et al., 2020). There are several categories of medications 
used to treat IBD and the goal in each approach is either to manage flare-ups by   inducing 
remission when symptoms are present or to help maintain remission by preventing future flare-ups 
and decreasing the time between episodes.  
Anti-inflammatory drugs, immune system drugs and a more sophisticated family of 
biologic drugs are often used to get symptoms under control. Enteral nutrition or tube feeding has 
been used quite successfully for the pediatric population and the probiotic E.coli Nissle has been 
approved for the UC patient population in Europe (Schultz, 2008). However, there is no one ideal 
treatment as therapies lack potency and have significant side effects. Because of this, patients often 
go on a lifetime journey to find the best medication or a combination of treatments that fit best for 
them. When first diagnosed, depending on the severity of those cases, patients do not always 
realize that IBD is a chronic and lifelong disease, requiring regular follow-up and compliance with 
medications to effectively manage the condition. Unfortunately, one third of all IBD patients 
relapse from symptom free period twelve months after stopping even the most sophisticated family 
of medication (Mankodi et al., 2019).  
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1.1.3 Emerging Treatments for Inflammatory Bowel Disease 
While most traditional IBD treatment centers do not offer dietary counseling as standard 
of care, integrating such model of care to support patients in IBD has shown promise (Regueiro et 
al., 2016). Specifically, studies have documented lower cost of care and improved patient 
outcomes. There is growing scientific evidence suggesting the central role of diet in the condition 
of the gastrointestinal tract (Bennet et al., 2017), and that natural diet modifications can offer a 
possible therapeutic intervention for IBD (Green et al., 2019). Because of this, nutritional 
interventions are a possible disease management option in IBD that can be used to improve short- 
and long-term disease activity and symptoms. As per Lewis et al. (2017), patient’s food 
consumption patterns (e.g. diets high in fats and meat, but deficient in fruits and vegetables) 
correlate with high IBD incidence and present themselves as an ideal therapeutic target that can be 
addressed through dietary modifications. While there is compelling evidence that diet can be 
helpful for targeting the most common pattern associated with an increased risk of IBD 
manifestation, diet as IBD therapy has not been integrated into the standard of care in my place of 
practice. Dietary changes, while difficult, can improve patients’ lifestyle and quality of life. 
Moreover, as Waters et al. (2005) have shown, patients who have a better understanding and 
knowledge of IBD disease display better compliance with treatments and medication, and are less 
likely to experience disease complications.  
1.1.4 Multidisciplinary Model of Care in Inflammatory Bowel Disease 
Multidisciplinary management of IBD brings together a group of health care 
professionals— gastroenterology and dietary management— to collaborate in their medical and 
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procedural expertise to best manage the patient’s medical condition (Healio, 2017). Involving 
regular diet counseling in the treatment of IBD care fits well with complex, hard to manage chronic 
diseases with comorbid behavioral conditions. The involvement of nutritional counseling modality 
of patient care has its origin in primary care, but has not been sufficiently implemented in specialty 
care domains.  
While diet can be potentially helpful in managing periods of IBD flare-ups and remission, 
most gastroenterologists are unprepared to provide evidence-based recommendations to patients 
(Weber et al., 2019). This stems from the fact that most U.S. gastroenterology practitioners are not 
trained to use natural diet modalities and rely primarily on procedural and pharmacologic 
approaches to treatment (Zezos et al., 2017). Overall there is scant data regarding diet and IBD, 
particularly in adults so the natural reluctance for physicians is not to provide dietary advice. There  
are not as many well done trials to demonstrate its importance particularly when compared to the 
many pharmaceutical companies that have completed well conducted randomized controlled 
trials.  In contrast, the Dietary Approaches to Stop Hypertension, the DASH diet, has been well 
studied in the cardiac population and successfully applied for years. (Maddock et al., 2018). 
Moreover, recent scientific discussions of complementary and alternative medicine (CAM) 
support diet as a potential treatment and disease management of IBD (Winter et al., 2017.)  Since 
many IBD patients experience nutritional deficiencies, integrating nutritional counseling at my 
place of practice into each patient visit would prioritize preventive care and likely provide a unified 
and stratifying patient experience.  
The value of a multidisciplinary approach has been well-documented across disease 
management, especially in oncology care for cancer patients (Taberna et al., 2020). The same can 
be said about the above mentioned “cardiac diet” in cardiology and recently the multidisciplinary 
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approach in treating IBD patients at UPMC (Regueiro et al., 2016). In 2016,  Regueiro and others 
at UPMC adapted the medical home model to centralize patient care in order to enhance the quality 
of the medical experience and to reduce the cost of care . Integrating dietary referrals among 
behavioral therapies into the routine care of IBD patients would likely benefit patients and 
potentially result in fewer hospitalizations, emergency department (ED) visits, unplanned services, 
surgeries, and pharmacotherapies (Regueiro et al., 2016).  
1.2 Organizational System 
The Digestive Disorders Center (DDC) is under the Division of Gastroenterology, 
Hepatology, and Nutrition at University of Pittsburgh Medical Center (UPMC). The IBD Center’s 
goals are to provide excellent, high-quality patient care integrating compassion for the challenges 
patients face each day and translating latest scientific and laboratory discoveries into patient care. 
The mission of the UPMC Inflammatory Bowel Disease Center is to conduct IBD research and to 
test novel therapies in order to individualize patient care as the disease can affect any part of the 
digestive tract.  
Our IBD clinics operate with the help of eleven health care providers on staff and seventeen 
fellows. Seven of the health care providers are full-time faculty with a three-year specialized 
fellowship training in Gastroenterology, and three-year residency in Internal Medicine. Fellows 
are physicians who are pursuing a specialized training in GI. The remaining three are mid-level 
providers who hold either a Physician Assistant (PA) license or Certified Nurse Practitioner 
Degree (CNP) and specialize in digestive disorders.  
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My role in the department is clinical research coordinator where I independently oversee 
and manage pharmacological research studies under a faculty physician. I collaborate with the 
clinical and scientific staff on research projects and am responsible for the effective execution of 
several research protocols aimed at finding new therapeutic ways to treat IBD. I also work directly 
with both Crohn’s and ulcerative colitis patients and I witness daily the struggle that most patients 
experience with this disease. I work directly under the physician who is the Director of Nutrition 
Support services and Translational IBD Research at UPMC and his clinical team involved in 
patient care. My educational and professional training in the field and literature review on the 
topic, as well as my professional background in health care working with IBD patients, introduces 
some bias toward understanding my PoP. In my professional role, I have witnessed patients 
exhaust both pharmacological and surgical treatment options without being offered other disease 
management options such as nutritional counselling. I believe that I am able to effect change in 
my current position, as I am fortunate to have the support and guidance of one of the top 
practitioners in the field of IBD care here at UPMC. While I expect logistic and institutional 
resistance to some aspects of the proposed change, my PoP is strongly grounded in previously 
piloted by Dr. Regueiro’s efforts to employ a multidisciplinary paradigm of IBD patient care here 
at UPMC.   
1.2.1 Current Nutritional Support at the Digestive Disorders Center  
Nutritional support care is not integrated into the DDC in such a way that our nutritionists 
are routinely involved in the patient care as standard practice. While GI specialists can refer 
patients to dietary services, there is little outpatient nutritional management with IBD patients, and 
DDC physicians rarely make referrals to outpatient nutrition. Once a patient is diagnosed with 
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either Crohn’s or ulcerative colitis, our gastroenterologists will formulate and prescribe medical 
intervention and/or refer the patient to a surgeon if he/she believes surgical treatment is necessary. 
The surgeon will later refer the patient back to the gastroenterologist for further management and 
the care is sometimes coordinated with the patients’ primary care physician. For patients clearly 
struggling with malnutrition or weight issues, some GI practitioners will refer the patient to dietary 
services if the patient’s insurance allows it and if the patient is interested in working with outpatient 
nutrition.  
Dietician use for IBD is currently limited to the medical home insurance holders 
(Affordable Care Act), which has a dedicated dietician; the census in the medical home at UPMC 
is approximately 800 individuals. While medical home patients at UPMC have 24/7 access to 
gastroenterology services including behavioral health and dietary specialists (see Figure 1. 





Figure 1. UPMC Medical Home Coordination of Multidisciplinary IBD Care 
 
Currently, there is no multidisciplinary or multimodality paradigm of care in the DDC 
outside of medical home patients, and no outpatient dietary service clinics are integrated into the 
overall management of Crohn’s and/or ulcerative colitis putting those patients at significant 
disadvantage and driving the cost of care both to the patient and the system. According to data 
from UPMC health plan, IBD patients who had concomitant health problems (14% of the total 
patient pool) including mental illness, poor support system and pain utilized 46% of total care 
derived from injectable drugs, surgery and cost of medication (Figure 2. Regueiro et al., 2015).  
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Figure 2. Results from Regueiro et al. (2015) Demonstrating That 14% of UPMCPpatients with IBD 
Contributed to 46% of All Total Cost 
 
This data clearly demonstrates the need and an opportunity for the individual GI providers 
to follow a certain clinical pathway in which they integrate both nutritional and behavioral referral 
system to support and care for their patients. Although our division leadership is in favor of 
improving care and implementing dietary services into the standard of care, the rest of the 
practitioners may not be. This is strongly related to the current attitudes and knowledge base most 
physicians hold regarding the role diet might play in the disease management of Crohn’s and 
ulcerative colitis.  
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1.3 Stakeholder Analysis 
I based my stakeholder analysis on a network view that supporters, resisters, and 
influencers enhance the benefits and value creation toward mutuality (Sachs and Ruhli, 2011).  
When the group’s acceptance is required prior to implementation, almost all stakeholders must 
feel that the benefits outweigh the cost. This has helped me in identifying potential beneficiaries 
for addressing my (PoP). Key stakeholders involved in this PoP are (a) UPMC Healthcare System  
(b)  the Gastroenterology Hepatology and Nutrition Program Division Chief; (c) Gastroenterology 
Practicing Physicians (d) Second and Third Year Gastroenterology Fellows (d) Dieticians (e) 
Current and Future Patients.  
1.3.1 UPMC Healthcare System 
My next stakeholder is UPMC. UPMC prides itself as a “life changing medicine” 
healthcare paradigm of care. I would like to think that UPMC would be supportive of the proposed 
multidisciplinary approach in treating IBD patients, as this would directly touch upon the 
organization’s core values of shaping tomorrow’s future and clinical innovation. Figure 1. 
(Regueiro et al., 2015). However, the division would need support from the higher level of 
management in order for the new practices to take place at the DDC. The division and department 
administrators are just as important as the chief in determining whether nutrition will be a focus 
as they determine if money will be supplied. Challenges such as conflicts of interest may arise if 
the department’s patient treatment philosophies among physicians or if departmental business 
practices do not align with each other, or if there is a threat of loss of business. One would think 
departments would be eager to remind physicians to refer more patients to nutritional counseling 
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as this brings business to the hospital and likely results in improved patient care, but this is not the 
case here. Physicians and staff have less control than what is intimated and work under 
administrators who mandate what can and cannot be done.  
Last, but not least, physician's pay at UPMC is mostly based upon a salary and not on how 
productive they are and regardless of referrals made to other services.  That said there are 
production bonuses and if some individuals do not meet productivity goals, they may be eventually 
penalized or dismissed.  Currently, ancillary services are billed directly to the hospital and 
physicians are not incentivized. One should keep in mind that UPMC is in intense competition 
nationally for patients and research market, and it aims to be viewed as a destination treatment 
institution for national and international patients. Regardless of what is at stake, this stakeholder 
has significant power in my PoP.  
1.3.2 Gastroenterology Hepatology and Nutrition Program Division Chief 
The Division chief is tasked with management and supervision of all the activities and 
operations of managing the DDC. Currently, the Division employs a total of eleven full-time 
teaching faculty and seventeen fellows in training. The chief assumes management responsibilities 
for assigned programs, policy, and trainings and monitors the overall efficiency and effectiveness 
of services rendered. He also monitors and approves expenditures and implements adjustments. In 
his view, the problem with nutritional interventions is that “the science is weak on demonstrating 
a [diet] difference in outcome.” When prompted to consider new treatment paradigms integrating 
multidisciplinary teams he confirmed this “would not find strong objections” at the DDC. 
However, in order for the change to take place all physicians have to agree that nutritional factors 
improve long-term patient outcomes.    
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1.3.3 Gastroenterology Practicing Physicians at the Digestive Disorders Center 
Since treating physicians are committed to serving their patients and are charged with 
prescribing the best available treatment, they are the most evident stakeholders in this PoP. 
Currently, the problem of practice that I have identified at the DDC is that gastroenterology 
practitioners do not utilize dietary referrals routinely. While some physicians that I have 
interviewed make referrals to nutrition for reasons such as malnutrition or weight management, 
others remark that nutritionists who are part of the group “can sometimes jump in and answer 
questions.”  
On the other hand, my interviews with faculty physicians suggested that diet knowledge 
and attitudes of GI practitioners varied. One GI physician shared that some of “the providers do 
not put enough emphasis on diet” in managing IBD symptoms. Doctors often feel pressed for time 
during their visit with the patient, which often leads to loss of opportunity to discuss options and 
result in unaddressed health questions. One of the mid-level provider interviewees shared that the 
physicians subjectively decide on a case-to-case basis on how much time they should spend on 
educating the patient. This might be determined by the level of the patient education or 
background, patient involvement in their own care and/or family support and resources. It often 
begins with education by the physician and then moves downward to the ancillary staff during the 
patient’s initial visit. This education process does not always allow addressing questions related to 
diet and lifestyle adjustments and are highly individualized based on the providers’ own personal 
bias.  
Lack of clinical trials demonstrating diet efficacy to discuss the nuances of dietary therapy 
was also voiced. Still, most of my responders agree that that there is a knowledge gap in physician 
understanding of IBD diets as therapy. My empathy interviews with seasoned GI physicians 
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suggest these practitioners have varied degrees of understanding regarding nutritional 
interventions and their scientific value. This is also supported by my literature review, which 
highlights the same problem among gastroenterologists. In a study by Holt et al. (2017), 
researchers explored whether patients and various providers considered diet important in the 
management of IBD. The study demonstrated that 82% of gastroenterology specialists considered 
diet to have a role in symptomatology and nutritional deficiency as it relates to malabsorption and 
dietary restriction. On the other hand, only 26% percent of patients reported receiving dietary 
advice from their treating physician.  
As mentioned by another physician I interviewed, “The GI doctors are likely either not 
involve or only tangentially involved [diet], and my opinion is that any particular physician’s 
opinion on diet does not necessarily permeate to the patient.” Furthermore, some mid-level 
providers felt that “patients need to be educated on day one and understand the role that diet plays 
in their disease management.” How effective physicians are at improving patient outcomes 
contributes to a stronger relationship and trust/confidence in the patient toward the physician. 
1.3.4 Gastroenterology Fellows 
The next group of stakeholders are early career gastroenterology practitioners who are 
about to depart from the DDC upon their graduation from the UPMC fellowship program. Many 
of them will start careers as independent GI physicians and either plan to join private multispecialty 
groups or hospital-based practice. While this group has the lowest stakes, the fact that they will 
have spent much of their time training as fellows is worth investigating. I believe their diet 
knowledge and attitudes in treating IBD patients are worth examining as I expect their attitudes 
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and beliefs surrounding diet to be formed early. This is mostly due to their prior experience with 
the fellowship training program received at UPMC. This new group of gastroenterologists will 
dedicate their life-long approach in treating patients based on the opportunities and challenges that 
practitioners are experiencing. Because of this, I estimate that this group of stakeholders have a 
potential role in creating a culture where new ideas and approach to treatments can be tested and 
evaluated.  
Currently, fellows do not have a dedicated nutrition service rotation, which limits their 
knowledge of nutrition and nutrition interventions. In other words, fellows have limited time to 
complete an elective training in nutrition services as the program curriculum is currently packed 
with inpatient rotation requirements.  
1.3.5 Dieticians 
  Another important group of stakeholders are the DDC nutritionists. As per my empathy 
interviewing they had reported a great challenge in getting patients to be seen or to be referred to 
medical nutrition for many reasons such lack of knowledge from a physician standpoint on the 
importance of nutrition, but also lack of insurance coverage for these types of referrals. Based on 
their knowledge, medical nutrition appointments with dietitians are only covered by insurance if 
it is coded for Diabetes Mellitus or Chronic Kidney Disease. Patients tend to not want to attend 
these appointments since they would have to be charged co-pays, but nutritionists were not certain 
on the out of pocket cost of an appointment with a dietitian. In addition, they reported that as a 
society we do not have the best nutritional values which makes many patients devalue this type of 
appointment. 
15 
1.3.6 Digestive Disorders Center Patients 
In my opinion, the most important and most affected group of stakeholders are current and 
future patients. Patient voice is rarely sought in the physician treatment making models (Kane et 
al., 2014). The relationship between patient and a physician is at the heart of good medical care 
and it is especially vital when choosing and implementing medical treatment. Empathy interviews 
with and observations of patients and providers at the DDC support the current literature that the 
department rarely refers IBD patients to professionally guided dietary plans.  
My empathy interviews with three male and female patients in their 20-30s confirmed that 
those who had been diagnosed with IBD lacked the proper understanding and guidance for years 
on how to adjust to their life post-diagnosis. The symptoms of IBD can be draining and lead not 
only to unplanned life changing surgeries like colectomies, but also affect patients’ mental health, 
inducing anxiety and lifetime of depression. Additionally, a study by Anderson et al. (2018) 
reported that IBD patients who experience poor quality of life are at risk for opioid use, which can 
lead to addictions. Because of this, many patients agreed that it would have been very helpful to 
have met with both a dietitian and a behavioral health specialist and then continued to meet with 
them post-diagnosis to adjust their lifestyle. Many struggled with how Crohn's (and other digestive 
diseases) can uniquely affect them in their daily living.  
Additionally, lack of physician time in the patient encounter provides only a few minutes 
of time dedicated to patient education. This approach is rarely sufficient as the likelihood that the 
patient understands the disease in the short amount of time given during an office visit undermines 
the patient’s confidence in the nutritional care. Studies show that in order to manage that thin line 
between how much information is necessary and when it is not enough, patients must be adequately 
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informed about their disease. (McDermott et al., 2018).   With the currently practiced model of 
care at the DDC, the average amount of time that a physician spends with patients varies.  
1.3.7 UPMC Demographic and Clinical Predictors of Inflammatory Bowel Disease  
The IBD clinic serves approximately 300-400 IBD patients per year with the bulk of the 
patients diagnosed with Crohn’s and Colitis (75%) and there are approximately a total of 3,500 
patients followed clinically at UPMC. Crohn’s disease appears to be more prevalent in women; 
however, ulcerative colitis is more common in men (Betteridge et al., 2013). In general, IBD risk 
factors include family genetics, ethnicity (more common among Caucasians vs. other racial/ethnic 
groups) and family history. Spearheaded by David Binion, MD researchers learned that the groups 
with the highest prevalence of IBD included those who were unemployed, black, or with 
comorbidity psychiatric and other illnesses (Click et al., 2016). Our IBD clinic serves new and 
returning patients, and approximately 10% of the total 30 - 40 patients annually who are newly 
diagnosed within the UPMC system are seen in the DDC.  
1.4 Other Lessons Learned From Improvement Tools 
In my investigation of this problem of practice, I observed that many of the DDC faculty 
are not committed to the integrative approach of combining conventional and complimentary 
strategies to manage IBD patients. I detected that , in lieu of helping patients navigate the difficult 
terrain of IBD diets, many physicians often fail to address the possible root causes for the disease 
(i.e., environmental factors such as gut flora or diet) with varying philosophies. On the other hand, 
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insurance compensation might be a key limitation in involving some nutrition support in patient 
care. I speculate that if the cost of nutritional counseling were reimbursed, some GI providers 
would be more likely to refer their patients, particularly as this intervention poses no risk to the 
conventional pathway of treating IBD patients. Based on my investigation of the referral process, 
medical nutrition appointments with dietitians are only covered by insurance if it is coded for 
Diabetes Mellitus or Chronic Kidney Disease. Patients who do not qualify tend to avoid these 
appointments since they would have to cover the cost of such visits. Nonetheless, the lack of 
knowledge from a physician standpoint on the role of diet in IBD often undermines and devalues 
this type of appointment for patients. Additionally, most patients are simply not aware that 
nutritional management might be helpful in reducing their IBD symptoms as well as to lead to 
improved well-being. Currently at the DDC the majority of physicians do not offer a regular 
opportunity to the patient to consult with a dietitian.   
1.5 Statement of the Problem of Practice 
My problem of practice is that the gastroenterology practitioners at the DDC underutilize 
nutritional services when managing signs and symptoms of inflammatory bowel disease.  
1.6 Review of Supporting Knowledge 
Although scientific research points to the positive effect of diet adjustments as an integral 
part of disease management, using diets as IBD therapy is rarely utilized within my place of 
18 
practice. Grounded in this problem, I sought to review literature potentially related to the deficit 
in nutritional referrals rate among IBD physicians. In the subsequent section, I will review the 
supporting knowledge regarding what is currently known about IBD treatments, the use of diet 
therapy in IBD, GI physicians current referral practices, and their knowledge of diet.   
1.6.1 Current Medications Used In Treating Inflammatory Bowel Disease 
Corticosteroids are anti-inflammatory drugs that are used to induce remission via 
suppressing the immune system in order to treat moderate to severe CD (Crohn’s disease) 
symptoms. (Yang et al., 2002). These medications are intended for short-term use as they can cause 
serious side effects. They are non-specific in nature as they target the entire immune system rather 
than specific sections of the affected tract where the inflammation occurred. Corticosteroids are 
generally very powerful, but cannot be used long term. 
Immunomodulators are used to maintain long-term remission by modifying the immune 
system’s reaction to inflammation. This family of medication usually works over extended period 
of time by calming down the body response, (Lichtenstein et al., 2009). It usually takes three to 
six months to assess the medication’s effectiveness. Immunomodulators are often used in 
combination with faster acting treatments like corticosteroids. They can be injected or taken in pill 
form, but can have serious side effects such pancreatitis or liver test abnormalities. Some 
immunomodulators cannot be used in pregnancy, and others can lead to increased rates of cancer 
and infection. 
Antibiotics are used to treat active CD or complications of IBD such as abscess (pocket of 
pus), post-surgery pouchitis (swelling of intestinal pouch), or fistulas (abnormal connections of 
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the intestine), or to fight intestinal bacterial infections such as C. difficile that cause persistent 
diarrhea, (Nitzan et al., 2014).  
Biologic therapies are used both in CD and UC and are a relatively new, but very costly 
form of therapy used in individuals who failed to achieve remission using conventional therapies. 
In some cases biologic therapies are used from the onset of the disease. (Yu et al., 2018). These 
types of drugs are a group of genetically engineered antibodies made from living organisms in a 
laboratory. Biologic therapies target part of the overactive immune system. They can be very 
effective for some people, especially those at risk of progression and disease complication.  
However, most patients fail or do not respond to biologics in the long term. Unlike others, these 
drugs do not suppress the whole immune system, but rather, work in precision to target certain 
proteins and enzymes precipitating the inflammation. The side effects of these drugs can range 
from reactivating infections, such as TB, to developing skin conditions or some cancers. A 
percentage of individuals will eventually develop resistance to these drugs and experience a 
decrease in its effectiveness, while some have allergic reactions from the start. Some biologics are 
administered as infusions a few times a year.  
Aminosalicylates (5- ASA) are not approved by the FDA to specifically target IBD; 
however, they can be effective in reducing local intestinal inflammation in mild UC in some 
individuals. Used as pills, enemas, or suppositories, they are especially effective in decreasing 
inflammation of the lining of the intestine. They are considered the safest IBD medication, as they 
usually do not increase the risk of infections or cancer in patients. (Crohn’s & Colitis Foundation, 
2020).   
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1.6.2 Surgical Interventions 
Surgery may also be performed, from bowel resections (removal of small or large 
intestine) and colectomies (colon removal) to fistulas and strictureplasty procedures (tunneling and 
blockages of digestive tract). Unfortunately, many patients at some point in their life face the risk 
of life-altering surgery to manage their condition. An estimated 70% of  CD and 25% of UC 
patients will need some type of surgical intervention as a result of the disease progression and 
complications or poor response to medication. Many patients end up with permanent stoma, which 
diverts emptying of the bowels to an external pouch. (Crohn’s & Colitis Foundation, 2020).   
1.6.3 Historical Background on Inflammatory Bowel Disease Diets 
The anti-inflammatory diet or the elemental diet have been available for decades 
(Yamamoto et al., 2005), but are underutilized as dietary management for patients with IBD at the 
DDC. This dietary management is usually presented in a model that offers three enteral nutrition 
dietary strategies: polymeric, semi-elemental diet and elemental diet, all of which have been 
proven to provide the tools necessary to improve patient results (Verma et al., 2000). Enteral 
nutrition (either oral diet or tube feeding) improved patient outcomes in 80% of patients on 
elemental diet (ED) and at least 55% on polymeric diet (PD) leading to clinical remission in those 
patients. (Verma et al., 2000). These therapies need to be uniquely adjusted to reach every patient 
via integrative approach to treating and healing the gut using a combination of anti-inflammatory 
diets. I feel especially optimistic about this problem, as the supervising physician I work with is a 
physician scientist living with Crohn’s disease himself and is especially dedicated to improving 
patient outcomes. 
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 Like most university hospitals, the DDC has a mission which encompasses high-quality 
care, innovative therapies, and positive patient outcomes. As I consider our organization, I find 
our physicians and staff are very committed to helping our patients to vanquish inflammation, 
manage disease symptoms, and restore quality of life. Because of this, I find the center’s 
comprehensive approach to offering opportunities to participate in personalized treatment plans as 
encouraging in affecting my problem of practice.  The emphasis on funded research, dedicated 
staff, and finding a cure for IBD, permeates all aspects of caring for those diagnosed with the 
disease, including quality of life issues. These goals are shared with all the stakeholders involved 
in the patient care.  
1.6.4 Inflammatory Bowel Disease and the Western Diet  
In a systematic review of nineteen studies evaluating dietary factors, such as the western 
pattern diet (i.e., high in fat and animal protein, low in fruits and vegetables), Hou et al., (2011) 
concluded an increased risk of both CD and UC prevalence. Moreover, a study by van den 
Bogaerde et al., (2001) concluded that Crohn’s patients reacted to food, yeast and bacterial 
antigens at a notably higher level compared to the control group. In a similar study, Shivashankar 
et al., (2017) found that food additives such as emulsifiers and preservatives caused significant 
inflammatory reactions in the gut in animal studies.  The same study established that IBD is more 
common in industrialized countries such as North America and Europe and those who recently 
immigrated to western countries are at higher risk to develop both diseases. 
This finding suggests a complex relationship between the role of the environment and 
genetics in the onset of the disease, hypothesizing the causative role of diet in some individuals 
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(Shivashankar et al., 2017). While the cause and effect of inflammation and diet continues to be 
under investigation, a number of research studies have concluded that dietary antigens can be 
activated by certain foods.  (Shivashankar et al., 2017). This mechanism appears to have a direct 
effect on the mucosal layer of the intestinal tract that ultimately triggers the body’s autoimmune 
system reaction leading to the onset of inflammation.  
1.6.5 Environmental Risk Factors and Inflammatory Bowel Disease 
A number of environmental theories have been explored over the last several decades 
defining environmental causation or risk factors, such as the use of antibiotics and childhood 
hygiene hypothesis among others (Molodecky et al., 2010). The use of antibiotics and especially 
prolonged use of greater spectrum of microbial coverage of antibiotics has been found to interfere 
with the normal bacterial flora of the gut found in healthy individuals and leading to an  onset of 
inflammatory bowel disease ( Nguyen et al., 2020). To prevent this from happening, certain 
therapies such as diets or the oral use of probiotics were found to help restore the natural 
microbiome. Patients were given a particular diet in order to restore gut health and microbe 
diversity to repopulate the natural bacterium found in natural foods such as fruits and vegetables 
(Khan et al., 2019). While this approach might not necessarily be the cure all, it has a significant 
chance to improve the signs and symptoms in those who are affected by IBD.  
Similarly, childhood hygiene hypothesis suggest that individuals raised in rural conditions 
that are less sanitary and away from hygienic urban environment and in close contact with nature 
(children playing in and even eating dirt) had a lower chance at developing IBD (Klement et al., 
2008). This stems from the theory that an exposure to certain germs and childhood infections helps 
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the intestinal microbiome to develop a strong immune system. Postulated by Furness et al. (1999), 
roughly 80% of the immune system is found in the gut and diets that are composed of highly 
processed foods contribute to gut dysbiosis. When dysbiosis (bad bacteria) are fed by high fat and 
sugar diets, and deprived of natural fibers found in fruits and vegetables, it causes an overgrowth 
of specific bacteria species.  
Pathogens such as yeast, mold, fungi and parasites are hypothesized to be heavily related 
to leaky gut syndrome and the imbalance of mediators, such as prostaglandins, which manifest in 
autoimmunity and chronic inflammation of the gut in some individuals (Limdi et al., 2016). 
Because of this, is theorized that many IBD patients can be helped by implementing natural diet 
modifications and replacing old eating habits with healthy (e.g., low-fat, low-sugar, and sometimes 
gluten- and dairy-free) foods prepared from fresh ingredients (Lewis et al., 2017).  
1.6.6 Complementary and Alternative Medicine in Inflammatory Bowel Disease 
The utilization of non-medical therapies such as the use of herbs and minerals to address 
signs and symptoms of IBD has been growing and slowly changing the health care of individuals 
with IBD especially in the last few years. They can be generally broken down into three categories 
of complementary (used together with conventional medicine), alternative (used in place of 
conventional medicine) and integrative (combining of conventional and complementary) 
therapies.  (Winter et al., 2017).  The use of vitamins, probiotics and mineral supplementation 
along with medical cannabis, acupuncture, diet, sleep and stress management puts patient in charge 
of their own personal care. According to Winter et al., (2017) as this trend continues to grow it is 
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important  that some models of CAM be integrated into IBD care as they bring the possibility of 
substantially improving patient outcomes and lowering the cost of care.   
1.6.7 The Use of Diet in Inflammatory Bowel Disease  
While nutrition is a component of disease management, the use of specific diets have not 
been fully integrated into the IBD paradigm of care. Since there is limited research in the area, 
physicians find it hard to advocate for certain approaches as there is a limited understanding of 
how diet can have a modulatory effect on the clinical course of the disease (Weber et al., 2019). 
However, recent findings on how the microbiome affects health and its overall importance in 
immunity suggests that the microbiome has a potential role in IBD and it should no longer be 
underestimated (Khan et al., 2019).  
A subgroup of participants in a Dutch study for instance, concluded that diet manipulation 
in IBD is more successful than the use of medication used to treat the disease (de Vries et al., 
2019). Additionally, a study by Kakodkar & Mutlu (2017) suggested food elimination and diet as 
IBD therapy to be a mechanism to decrease inflammation as some individuals experience 
immunogenicity or allergies to certain foods such as gluten or diary. While the variability in 
response varies from person to person and data is often inconclusive, there are many diets in the 
medical literature to lay precedence for IBD. (Kakodkar & Mutlu. 2017).  
In the U.S., the use of IBD specific diets has not been fully integrated into the paradigm of 
care by the American Gastroenterological Association (AGA). The cost of evidence-based 
medicine and its rigorous pharmacological trials are substantial and time consuming and this 
weighs heavy on the potential prospect of medical diet studies (Weaver 2017). Currently the 
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gastroenterological community finds diets to have a very subtle effect as it takes an extended time 
to have an impact on the clinical history, but offers a promising treatment modality.    
According to the co- director of the UPMC IBD Center, the lack of a formally guided 
system to assist physicians in tracking food elimination strategies like a laboratory test tends to 
discourage many practitioners from attempting this approach. Furthermore, the huge emphasis on 
drug therapies and surgical interventions likely prevent many in the industry from conducting 
nutritional studies, as they are not particularly well funded, suggesting an ethical barrier. Along 
the same lines, a research by Limdi (2018) finds that basic and clinical research, guiding 
conventional gastroenterology practitioners finds limited evidence of dietary support in preventing 
or triggering IBD. The scientific evidence is often inconclusive or too difficult to decipher citing 
lack of objective evidence for the use of any specific diet modifications. For the same reason, 
gastroenterology practitioners historically are not trained in natural diet modalities and rely on 
registered dietitians to only coordinate aspects of care related to malnutrition and weight 
management in patients. Aside from bowel rest, a period of time where oral nutrition is stopped 
and substituted with intravenous or tube feeding (food goes directly to either the vein or 
stomach/small intestine to bypass the mouth), dietary advice plays only a small part in the 
established AGA guidelines (Durchschein et al., 2016).  
On the other hand, a number of alternative specialties such as natural or integrative 
medicine practitioners and the American Academy of Nutrition and Dietetics (eatrightPRO) have 
been filling the gap and helping IBD patients to navigate the difficult terrain of inflammatory 
bowel disease. Currently, eatrightPRO offers an array of dietary approaches to help manage 
inflammatory bowel conditions. Diets such as carbohydrate exclusion diets, Mediterranean, low 
fiber, low FODMAP, gluten or dairy free diets along with anti-inflammatory nutritional plans 
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might serve as a symptomatic treatment of IBD. (Crohn’s & Colitis Foundation. 2020). Because 
of the individualized nature of IBD (different patients might be affected differently), no single diet 
works for everyone. As such, it is important to emphasize for each patient to work closely with a 
registered nutritionist to best address the signs and symptoms of the disease and to promote gut 
healing during periods of flare ups. Additionally, a study by Zimmer and colleagues concluded 
that maintaining either vegan or vegetarian diet significantly improved gut microbiota by reducing 
the number of terobacteriaceae that are usually found in IBD patients (Zimmer et al., 2020).  
1.6.8 Referring Patterns in Gastroenterology  
The utilization of outpatient dietary support by gastroenterologists is currently limited to 
cases of nutritional deficits or weight management.  In a study conducted by Tinsley et al. (2016),  
only 64.9% of all providers routinely (every, or almost every visit) assessed their patients 
for nutritional deficiencies. The remaining 31.2 % evaluated patients “occasionally” when 
malnutrition was suspected and 2% of providers admitted to never assessing patients for 
malnutrition. Since malnutrition is highly prevalent in IBD, early identification of patients could 
potentially prevent disease complications in the most vulnerable individuals. Consecutively, 
84.2% of GI providers reported their diet knowledge was “very good”  or “good” and only 15.8% 
of providers assessed their IBD nutrition knowledge as either “fair” or “poor.” On the other hand, 
a patient survey found that only 7% of patients talked to their physicians about nutrition while 11.6 
% of patients reported that dietitians discussed the topic with them. The remaining 15.4% of IBD 
patients stated that they never discussed nutrition with any provider. On the other hand, when 
asked about their knowledge of nutrition in IBD, 87% of dietitians rated their knowledge as “very 
good”.  The study concluded that significant nutrition knowledge gaps are evident with most 
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physicians and nurses stating that they were not aware of a published guidance pertaining to 
manifestation of malnutrition among IBD patients. This is even more concerning than lack of 
dietary management alone, because patients with malnutrition are at higher risk for disease 
complications such as sarcopenia (skeletal mass loss), decreased bone strength, and ultimately 
physical disability (Scaldaferri et al., 2017). 
1.6.9 Inflammatory Bowel Disease Dietary Practices and Understanding Among Patients   
A dangerous path of self-regulating and food restricting patterns is not uncommon among 
IBD patients who are trying to manage their own diet (Larussa et al., 2019). Since some patients 
believe that diet modification has a role in the disease progression, many patients take upon 
themselves to change their diet in the absence of professionally guided dietary referrals and 
oversight. In other words, they may limit or restrict certain food or food groups to prevent disease 
exacerbation. The self-adoption of dietary exclusion can sometimes lead to nutritional deficiencies 
if not done under the supervision of a health care professional (Larussa et al., 2019). Advice taken 
from the internet or other questionable sources can sometimes backfire or simply be found 
ineffective.  
A common long-term consequence of nutrients that are withheld are weight management 
problems and serious nutritional deficiencies. For example, Zallot et al. (2013) identified that close 
to 40% of their responders who had IBD diagnosis restricted fruits and vegetables to prevent future 
relapse, creating unintended consequences. Additionally, there may be changes in appetite and 
enjoyment of eating which can negatively affect the individuals’ relationship with food (Limdi et 
al., 2015). While dietary modifications can be a very effective tool in moderating episodes of 
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disease flare-ups, food exclusion in IBD patients should not be done without guidance from trained 
professionals. This underpins the importance of gastroenterology practitioners having detailed 
discussions with patients regarding their dietary habits and management.   
1.6.10 Practitioners’ Diet Knowledge 
Most physicians reported that nutritional education was not part of their medical training, 
and because of this, can only provide basic recommendations to patients (Tinsley et al., 2016). In 
situations like this, patients might interpret the physician’s lack of expertise as a form of 
disapproval for the interaction that diet might play in the disease. As previously stated, the 
American Gastroenterology Association lacks well-established guidelines related to natural diet 
modalities. My review of literature suggests that a selected group of IBD patients often ask their 
physicians for dietary recommendations, but rarely receive satisfactory answers from their 
physicians (Shivashankar et al., 2017). Because of low knowledge and comfort among GI 
practitioners related to the current strengths and limitations of IBD dietary interventions, a 
registered dietitian should be required to counsel with each patient.  
A new approach aimed to integrate alternative medicine is also on the rise. However, 
results are mixed regarding physician acceptance and endorsement of complementary and 
alternative therapies. A study by Gallinger et al., (2014) found that most physicians agree that 
complementary and alternative medicine would not compromise the conventional therapies 
currently available and its utilization should be recommended to patients. On the contrary, a study 
conducted by Lindberg et al., (2014) offered the opposite perspective; physicians expressed a 
concern that non-pharmacological approaches to treating IBD (e.g., CAM) would become more 
popular, ultimately eliminating the need for conventional medicine. This is an interesting 
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perspective as it speaks to some of the barriers and limitations (subjective bias) that some 
physicians might have about the therapeutic nature of dietary interventions.  
1.6.11 Summary  
Upon review of the professional knowledge and literature, I have realized that many 
stakeholders are able to recognize that IBD is shaped by patients’ dietary practices and we can 
now assert with confidence that there is a knowledge gap in part due to physicians’ training. Both 
patients and practitioners have voiced the need for written guidance of IBD specific dietary 
information in accordance with validated tools to empower all stakeholders. Patients are in 
relationship with their doctors and their interest in diet therapies often depends on those very 
relationships. Therefore, it is essential that doctors initiate such conversations with patients and 
that nutritionists who have that knowledge engage with patients on regular basis. 
Educating GI fellows about dietary recommendations and nutritional therapies sets an 
important precedent in guiding clinicians on the use of natural food modalities for relief of signs 
and symptoms of IBD. An increase in the number of dietary referrals at the DDC could provide all 
stakeholders (physicians, patients, dietary service staff and the UPMC healthcare system) with an 
important treatment strategy for not only improving patient outcomes, but also reducing the cost 
of care associated with this illness.  
 Because nutrition plays an important role in not only promoting health, but also preventing 
disease, it is imperative that patients at the DDC are offered additional options to manage their 
Crohn’s and ulcerative colitis disease. This is what we know so far and what we hope to achieve, 
at least that is my interpretation of how my PoP shapes how I am seeing the problem. A stronger 
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focus on promoting early dietary intervention and looking at patient nutrition would likely result 
in lower disease complications and a reduction in major complications. Not endorsing any specific 
dietary protocols for IBD patients, despite the fact that large meta- analysis of randomized clinical 
trials (RCT) and observational studies demonstrated the effectiveness of dietary intervention in 
chronic disease management in the general population, make me question why similar measures 
currently are not present at the DDC.   
Several reports and scientific resources have been published to provide evidence-based 
guidance to support nutritional monitoring in IBD patients. One way to increase dietary referrals 
among GI practitioners could potentially be to increase physician knowledge of IBD diets and 
dietary services, which aligns with my theory of change.    
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2.0 Theory of Improvement and Implementation Plan 
In order to affect my problem of practice and to increase outpatient nutritional referral 
rates, my theory of improvement was designed to improve GI fellows’ knowledge base about the 
role that diet plays in treating IBD. My aim statement was that by the end of August 2023, the GI 
referrals of IBD patients to nutritional services would improve by 20% or more.  
The following three key drivers provided an opportunity for driving the change: GI 
fellowship training program, DDC faculty and fellows, and patient support/advocacy. Each of 
these primary drivers have secondary drivers which can contribute to achieving the proposed aim 
(see Appendix A). 
2.1 Primary & Secondary Drivers 
2.1.1 Gastroenterology Fellowship Training Program 
The fellowship program at UPMC is a three-year program accredited by the private 
advisory board of ACGME (Accreditation Council of Graduate Medical Education) which 
evaluates residency and fellowship programs internationally. The clinical scholar track includes 
approximately 36 months of clinical training and within the second half of the program trainees 
are able to purse research interests. During this time, they are given the opportunity to focus on 
individualized training based on their specific career goals to tailor their training.  
32 
The goal of each program is to provide fellows with foundation in clinical knowledge and 
practice, as well as to provide experience in integrating elements of basic translational science in 
gastroenterology and hepatology. These tracks usually have protected research time and provide 
fellows with flexibility based on specific interests. Currently, the division offers seven tracks 
involving the pancreas, liver, neuro-gastroenterology and IBD among others. The Intestinal Health 
and Nutritional Support track is very specific to temporary or permanent feeding disorders 
involving tube or intravenous feeding regimens also known as TPN. Fellows are trained to help 
patients avoid serious complications of TPN, but are not trained in natural diet modalities for IBD. 
Similarly, the lack of formal AGA guidelines for the treatment of IBD patients, as well as lack of 
diet-focused fellowship curriculum, pose limitations on this driver.  
 If the proposed education modules were deemed effective and engaging in conveying key 
diet information, then this would directly influence this primary driver to create a level of change 
within my secondary drivers. If successful, I hope to observe effects of my intervention by 
comparing baseline and follow-up GI fellows’ knowledge scores, which could directly impact my 
aim statement of ultimately increasing referral rates.   
2.1.2 Digestive Disorders Center Faculty and Fellows 
DDC faculty and fellows are my next primary driver. Their limited knowledge of DDC 
nutritional services as well as lack of endorsement of nutritional services and understanding of 
nutrition as a potential disease management option contributes to my PoP, and likely change in 
this driver could affect change in referral rates.  Taking root in a large training program, faculty at 
the DDC are fully committed and engaged in preparing fellows to become the next generation of 
practitioners under the very carefully crafted built in process of collaborative learning. Preparing 
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fellows is time consuming and a delicate task, as it entails giving fellows tangible support with 
hands on training and overseeing their overall experience. Fellows strongly rely on the knowledge 
and expertise of experienced physicians and the department compensates faulty for their 
instructional time. Fellows, by the nature of their training, rotate at different hospitals every few 
weeks (Presbyterian, Montefiore, Shadyside, Veterans Affairs [VA]) to enhance the variety of 
settings and complexity of patients.  
In order for this driver to be effective, faculty and fellows must practically and 
intellectually engage in improving and expanding patient care options. The support can take many 
forms, but both drivers must possess a mindset to broaden their knowledge and dedication to 
improve patient outcomes in meaningful ways. They are the perfect support to my aim, as both 
groups stretch out the learning process and participate in scholarly and educational activities and 
adhere to established practices and the mission of innovative patient care. Because the teaching 
collaboration and dynamics between faculty and fellows is so complex, changes in this area might 
be challenging, as they involve new initiatives and affect the currently set paradigm of patient care. 
However, the learning incentive provides an opportunity to both the DDC faculty and fellows to 
tap into the talents of carefully selected trainees and to motivate them to be change agents 
integrating best practices of care.  
2.1.3 Patient Support/Advocacy  
Patient support and advocacy is my third primary driver. Limitations identified under this 
driver relate to patients limited knowledge about nutritional services, their limited understanding 
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of nutrition as a potential disease management option, the quality of patient-provider relationship, 
and patient self-efficacy to make lifestyle changes.  
The nature of patient advocacy groups are that they have a mission to assist and take action 
to support people afflicted by disease. They are patient-oriented, non-profit and provide 
educational and emotional support to improve the quality of life to both patients and their 
caregivers (Rose, 2016). Patient advocacy meetings are very informal and members consist of their 
families and sometimes community opinion leaders. Depending on the positionality, they often 
collaborate with other local and national chapters in order to bridge their insights and experience 
into best treatment options. They serve as key opinion leaders and often connect to social media 
with their messaging and content and link with their local clinics and hospitals (Rose, 2016). Based 
on my empathy interview with the local chapter stakeholder, the Pittsburgh IBD Patient Support 
group is run twice a month at the Digestive Disorder Center with an average number of 6-8 patients 
per session. Some individuals float in and out, while others prefer more one-on-one interaction. 
The group organizer has had Crohn’s for 40 years and has been supporting and advocating for her 
fellow IBD patients for years. She is also very active with the Crohn’s & Colitis Foundation and 
the group runs through the Crohn’s & Colitis Foundation in partnership with UPMC. This driver 
already connects to the mission of educating and organizing resources and has a great chance of 
affecting change. The effects from this level of modulation will directly impact the patients and 
likely enhance the change idea given the goal to produce improved patient outcomes.  
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2.2 Other Potential System Change Ideas 
Future change ideas should include revisions to the local GI fellowship curriculum to 
supplement the existing GI training program outside of the surgical and pharmacological 
applications, integrate diet on some level at the DDC through model of care at UPMC and finally 
pursue revisions to AGA recommendations nationally. These were not selected in my PoP because 
they were not as feasible given my realm of influence. My intervention was to develop and 
implement a brief online education module on the role of diet in the management of IBD for 
gastroenterology fellows utilizing the Plan-Do-Study-Act of improvement science cycle. The goal 
of this PDSA study was to increase knowledge of IBD diets among GI fellows via the online 
education module. I aimed to investigate the current knowledge base of GI fellows as well as to 
gather key information to further target what changes I could make that would result in 
improvement. Standardized competencies can  address the lack of knowledge and  be later tailored 
to provide useful and appropriate knowledge to future cohorts of GI fellows.  
2.3 Intervention Description  
The education module outline is found in Appendix E. To determine which areas of natural 
diet modalities would be the most relevant to the current GI fellows, I sought out guidance from 
the UPMC-dedicated IBD nutritionist and investigated the most recent clinical trials with 
groundbreaking evidence of dietary approaches in managing IBD patients. I have designed and 
launched a four-phase education module for our gastroenterology fellows with a focus on the types 
of recommended IBD diets and current ongoing research. This online education module was 
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designed to introduce fellows to ideas of natural diet modalities in the management of IBD and 
their potential value in improving patient outcomes. The learning objectives of the education 
module were for the fellows to (1) identify dietary options for IBD patients, (2) identify the benefits 
of nutritional counseling, and (3) locate and understand outpatient dietary services at UPMC.   
The education module covered the importance of nutrition in IBD as well as discussed the 
currently available dietary recommendations for IBD patients. Additionally, the module presented 
research on the multidisciplinary model of care and discussed the major problem of malnutrition 
in IBD patients. After the education module, fellows were asked to identify dietary options for 
IBD patients and respond to why some patients might significantly benefit from nutritional 
counseling.    
2.4 Improvement Target & Inquiry Questions 
The intervention was to design and implement an online education module for the 1st, 2nd 
3rd and 4th year gastroenterology fellows on the role of diet in the management of IBD.  The theory 
of change for this project was that engagement with this educational module would increase 
fellows’ knowledge of IBD diets and lead to increased IBD patient referral rates to nutrition 
services. This investigation was driven by several inquiry questions: 
1. What are GI fellows' current referral rate of IBD patients to nutritional services and 
how does this change following participation in the education module? 
2. What is fellows’ current knowledge base regarding IBD diets and DDC nutritional 
services and how does it change following participation in the education module?  
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3. How often do GI fellows talk to patients about diet and does this number increase 
following participation in the education module?  
My theory of improvement is predicated on the theory of reasoned action, which is part of 
the physician decision-making model (Reyna, 2008). This theory proposes that physicians make 
subjective health care decisions that stem from their own personal bias and pertain whether certain 
measures are beneficial to prescribe. For instance, if they have a disapproving attitude toward the 
role of nutrition, they will be unlikely to make referrals to dietary management, despite the known 
advantages available to patients.  
In general, medical fellowships aim to accomplish a variety of goals established by the 
governing bodies and depend on a complex net of relationships between faculty, staff and the 
academic enterprise. They benefit both the individual trainee as well as the institutional culture via 
distinct standards and processes enhancing the reputation and the scholarly environment via 
individualized, clinical and research driven development (Karpinski et al., 2017). Prior limited 
attempts to assess gastroenterology fellows’ knowledge have primarily focused on determining 
nutritional knowledge as it pertains to TPN (intravenous) or enteral (tube feeding) nutrition support 
(Scolapio et al., 2008); however, it has not been explored in natural diet modalities. It is worth 
noting that the degree of nutritional curriculum in most GI fellowship programs is also thought to 
be grossly undersupplied. (Scolapio et al., 2008). My theory of improvement was proposed to 
address the cause and effect summarized in my Fishbone diagram (Appendix B). My theory of 
improvement included knowledge training of GI fellows and aimed to change the division’s culture 
as it relates to patient referral to dietary services. Our current culture is that GI fellows are not 
prompted to consider alternative means to the disease management, diminishing the opportunities 
to recognize and promote change. 
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2.5 PDSA cycle 
2.5.1 Overview 
The PDSA cycle is a four-step scientific process (Plan-Do-Study-Act), which is used as an 
analytical tool in the field of improvement science to guide the process of carrying out change 
(Perry et al., 2020). To address the above inquiry questions, in Phase I of my study (Baseline 
Assessment) I deployed a baseline (pre-intervention) survey with GI fellows within the University 
of Pittsburgh Department of Medicine. The setting of this study was the DDC housed in the 
Presbyterian Hospital. I employed an online survey with both qualitative (open-ended) and 
quantitative (closed-ended) items to evaluate fellows’ current knowledge and understanding of 
natural diet modalities. In Phase II, fellows’ participated in the education module. In Phase III and 
IV of the study, I aimed to determine if the change idea had improved the problem of low dietary 
service referral rates. Figure 1 highlights the study phases for the current inquiry project. 
  
 
Figure 3. Inquiry Project Phases Plan 
 
Physicians’ knowledge (i.e., what they know about treatment options) is shaped during 
their residency and later reinforced during fellowship training. I hypothesized that if fellows are 
educated on the role and importance of natural diet modalities in IBD, then they will refer more 
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patients to outpatient dietary services. I proposed to assess the second and third year cohort 
because, unlike the first year cohort who just began their training, they are the most advanced in 
the program. However, due to the initially low enrollment (12 participants), I decided to expand 
the survey to the 1st and 4th year fellows as well (total of 16). I predicted that GI fellows would 
approach the education module with some curiosity about the possibilities that this paradigm of 
care might offer in terms of viable treatment options for patients. On the other hand, I recognized 
that this change idea proposed above may also face challenges in getting buy-in from some fellows, 
as the recommendations lack formal AGA endorsement. In planning this PDSA cycle, I attempted 
to answer several inquiry questions as listed under my Improvement Target & Inquiry Questions 
section. Additionally, I expected that fellows would leave the education module with new 
knowledge regarding natural diet modalities in IBD, which would contribute to more conversations 
with their patients about diet, as well as increased referrals to dietary services.  
2.5.2 Do 
Baseline Assessment Survey (Phase  I):  I evaluated GI fellows’ knowledge and behaviors 
through a survey I developed and adapted for this improvement project (Appendix D). 
Specifically, the survey was based in the literature and adapted from previous studies of Duncan, 
Natarajan & Schwalm (2016) and Dahhan et al. (2015). This adapted survey included four items 
to assess fellows’ baseline knowledge of IBD diets, two items to measure awareness of nutritional 
services at the DDC, two items asking how often they speak with their patients about diet, and one 
item to gauge their current referral practices. It also asked additional background information such 
training year, fellowship specialty, any previous training in natural diet modalities, criteria for 
nutritional referral, and whether and how often they consult outpatient dietary services. The survey 
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items included multiple choice, Likert-type scales, and open-ended questions. Surveys were self-
administered by GI fellows using Qualtrics, a web-based software designed to develop and 
administer data collection and to export survey data into programs used for data management. 
Online Education Module (Phase II). This phase of the study introduced the fellows to the 
current literature and diet options in IBD. See Intervention Description and Appendix E for more 
information.   
Post-Module Knowledge Assessment Survey (Phase III): This phase of the study assessed 
fellows’ knowledge of IBD diets and nutritional services at the DDC immediately following 
participation in the education module. The survey items were identical to those in the Baseline 
survey (Appendix F).  
Post-Module Behavior Assessment Survey (Phase IV):  This survey assessed fellows’ 
behavior changes 30 days after participating in the education module. The survey items were 
identical to those in the Baseline survey (Appendix G).  
Data Collection Overview:  First, I sought approval and support from the Division Chief 
to engage the DDC fellows to take part in my inquiry project. Subsequently, I proceeded with 
gathering email addresses of all GI fellows, which were available on the University of Pittsburgh’s 
DOM Gastroenterology, Hepatology and Nutrition Fellowship website. With the support of the 
Director of GI Fellowship Program at UPMC, I sent an email introducing fellows to the training 
and inviting them to participate. See Appendix C (Recruitment Letter) for details. I purposely 
collaborated with the Director to distribute the study information to get the attention of all fellows 
in the program. Participation in this study was voluntary; however, with the endorsement from the 
Director, I expected the majority of fellows to take part in the study.  
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Fellows were expected to complete the baseline assessment prior to the education module. 
After completion of the baseline assessment survey, they were able to select a link to take them 
directly to the education module designed as part of this intervention (Phase II). The respondents 
were not be able to return to the baseline assessment once they left the webpage to assure the 
integrity of the data. The total time for both survey and the training module was approximately 40 
minutes.  
Phase III post-module knowledge assessment was available immediately following the 
education module. Participants were able to select a link in Qualtrics to take them directly to this 
follow-up survey (Appendix F). Phase IV (post-module behavior assessment Appendix G) was 
completed via a Qualtrics link sent 30 days later via email to those fellows who participated in the 
education module (Appendix E). They had one (1) week to complete the survey; however, I ran 
into issues with low participation and I needed to send a few additional reminder emails outside 
of the planned 5 days after the study was initially deployed, as fellows were extremely busy with 
their rotations. Ultimately, all 2nd, 3rd and 4th year fellows and a smaller group of 1st year fellows 
participated in the study. 
2.5.3 Study 
I used descriptive statistics to summarize the survey results and categorical coding to 
analyze open-ended survey items. My plan was to use statistical tests to compare referral rates and 
knowledge pre/post module with statistical significance level set at p<0.05. I wanted to compare 
pre/post results to demonstrate whether the education module had any impact on fellows’ 
knowledge and behaviors (i.e., making outpatient referrals, talking with their patients about diet). 
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2.5.4 Act 
My goal for this PDSA cycle was to investigate whether a brief education module was able 
to increase GI fellows’ patient referral rates and frequency of conversations with patients about 
IBD diets (i.e., behavior change in the fellows). Increasing outpatient nutrition referrals is key to 
improving patient outcomes, and ultimately the quality of life of our patients. If the intervention 
was successful, I could recommend that stakeholders include this training module as mandatory 
for all fellows moving forward. If the intervention did not produce any change in the primary 
outcomes, I could seek feedback from stakeholders and revisit the driver diagram to test a 
subsequent PDSA cycle with revised inquiry questions.  
2.6 Systems Measures 
My selected measures helped me determine if the intervention I was employing was 
making a difference.  All assessment questions have been deduced from validated literature and 
assessed for validity and relevance by the faculty at the University of Pittsburgh School of 
Education.  Process measures included in the current inquiry include the education module and 
fellows experience. The driver measures include key drives, and outcome measures included in 
the current study addressed presumed deficiencies of the system. Last but not least, balance 
measures monitored for hidden effects as they relate to outcomes. 
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2.6.1 Process Measures 
To evaluate if the process of incorporating the online module was effective, I have 
implemented baseline and post intervention assessments.  Another process measure were fellows 
participating in the module and their gauging of the process. Elements such as the perception of 
the value of the content as well the mode of online delivery were assessed and concluded to support 
the study process.    
2.6.2 Driver Measures 
The driver diagram in Appendix A was developed for the purpose of articulating and 
testing my theory of improvement as well as recognizing the connections to primary and secondary 
drivers. All three key drivers -GI Fellowship Training Program, DDC Faculty and Fellows, Patient 
Support/Advocacy-  provided an opportunity to affect change and each of these drivers contributed 
to achieving the proposed aim. I was able to observe effects of my intervention by comparing 
baseline and follow-up GI fellows’ knowledge scores, which directly impacted my aim statement 
of affecting referral rates.   
2.6.3 Outcome Measures 
Currently our GI clinic operates without the routine use of dietary services to care for 
Crohns & UC patients. Increasing GI fellows’ knowledge base and discussion with patients was 
directly related to my aim statement of increasing patient referral. The implementation of my 
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education module will address this deficiency and ultimately improve the frequency with which 
GI fellows refer patients to outpatient dietary services for the support of the disease management.   
2.6.4 Balance Measures  
Steps were taken to avoid any stressors or to risk confounds among fellowship trainees 
during the data collection period. While I have initially run into issues with low subject enrollment 
likely caused by overwhelming duties and rigorous GI training program, the potential for negative 
impact was minimized at conception. The goal was to make the education module brief and to the 
point as well as engaging.  The analysis of the open-ended questions at post intervention supported 
the measures for this cycle.  
2.7 Analysis of Data 
I downloaded the survey results from Phase I, III, and IV from Qualtrics into Microsoft 
Excel, and calculated descriptive statistics (means (SD) and percentages). Open-ended questions 
were treated as nominal data and qualitatively coded and categorized. To compare pre- and post-
intervention survey results to examine whether the education module had any impact on fellows’ 
knowledge or behaviors, additional statistical analyses were conducted using R 4.0.3 (2020) 
statistical software. I consulted with the Statistics Department to support me in conducting these 
analyses. Specifically, Wilcoxon signed-rank test was used to calculate the p-values for paired 
ordinal variables, and McNemar-Bowker test was used to compare nominal data. For the “select 
all that apply” questions, McNemar-Bowker tests were used to examine the difference in whether 
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the participants selected answers such as “unsure,” or “none of the above” at baseline vs. follow-
up. For questions without such options, McNemar-Bowker tests were also used to examine pre- 
and post-intervention differences in the selection of each possible option, and Bonferroni 
corrections were used to adjust for inflated number of false positives. Statistical significance level 
was set at p <0.05.  
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3.0 PDSA Results 
3.1 Phase I: Baseline Assessment 
My study enrolled a total of seventeen (17) medical fellows who were part of the UPMC 
Gastroenterology Fellowship Program. One participant only partially completed the study and 
their data was excluded from any analyses, representing an overall participation rate of 95%.  
Among the 16 participants, four of the participants were 1st year fellows, six were 2nd year fellows, 
four were 3rd year fellows, and two were 4th year fellows. Specific sociodemographic data was not 
collected on the participants; however, 31% specialized in pancreatobiliary, 25% specialized in 
general GI, 26% specialized in the liver, 19% specialized in IBD, and 6% reported “Other” 
interests (Figure 4). At baseline, all fellows (100%) reported they had never taken a nutrition 
course in medical school (results not shown).  
 
 






IBD Liver Pancreatobiliary General GI Other
What are your fellowship specialty interests? 
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3.2 Phase III: Post-Module Assessment 
After participating in the module, the majority of fellows (87.5%) reported the education 
module was ‘very effective,’ while 12.5% reported it was ‘somewhat effective,’ and none reported 
it was ‘not effective’ (results not shown). Additionally, after completing the module, 87.5% of 
fellows reported ‘yes’ that they plan to refer more patients to outpatient nutritional services, while 
12.5% reported they would ‘maybe’ plan to refer more patients, and no one said ‘no’ that they 
wouldn’t plan to refer patients.  
Table 1 includes the results of the open-ended questions from the post-module knowledge 
assessment survey. The overwhelming majority of the fellows indicated that the information was 
very helpful in understanding the importance of integrating diet in IBD, and the variety of available 
diet options. Nearly 44% of fellows reported that they would use this information to have more 
conversations with patients and/or provide dietary recommendations to patients, while 31.2% said 
they would use the information for patient referral. About 25% of comments included positive 
feedback about the module, 18.7% requested additional data comparing the different diets and a 
printable version of the module to be used as a future resource, while 50% left no responses. One 
participant also suggested incorporating this training into the fellows’ standard curriculum.   
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Table 1. Phase III Post-Module Open-Ended Responses 
Question % (n)  
What was the most important information you learned?   
Importance of diet in IBD 37.5% (6) 
Variety/available options of diet 37.5% (6) 
Other 25.0% (4) 
How do you plan to use the information on natural diet modalities in IBD? 
Patient referral 31.2% (5) 
Provide recommendations/have more conversations 43.7% (7) 
Other 25.0% (4) 
Any other comments or feedback on the education module?  
Positive feedback/comments 25.0% (4) 
Requested additional data/resources 18.7% (3) 
“This should be consistently incorporated in the fellows’ curriculum” 6.2% (1) 
None/no response 50.0% (8) 
3.3 Comparing Fellows’ Knowledge from Baseline to Follow-up 
At baseline (Phase I), the majority of fellows reported they were ‘not familiar’ (68.8%) or 
only ‘somewhat familiar’ (31.3%) with the outpatient services offered at the DDC (Table 2). After 
participating in the education module, the percentage of fellows ‘not familiar’ with outpatient 
dietary services decreased to only 12.5%, while 87.5% reported to be ‘somewhat familiar’ and 
none of the fellows selected ‘very familiar.’ The McNemar test results indicated that participants’ 
familiarity with outpatient dietary services has significantly changed after the intervention 
(p<0.001).  
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Table 2. Fellows’ Familiarity with Outpatient Dietary Services at Phase I (baseline) and Phase III (immediate 
follow-up) 
Phase I Survey:  How familiar are you with outpatient dietary services at the DDC?  
Not familiar 68.75% (11) 
Somewhat familiar 31.25% (5) 
Very familiar 0% (0) 
Phase III Survey:  How familiar are you with outpatient dietary services at the DDC?   
Not familiar 12.5% (2) 
Somewhat familiar 87.5% (14) 
Very familiar 0% (0) 
NOTE: McNemar test was used to test difference in participants’ familiarity (‘somewhat’ or ‘very familiar’ vs. 
‘not familiar’) with outpatient dietary services at the DDC before and after the intervention; p = 1.00 (non-
significant).  
 
Table 3 includes the results of fellows’ knowledge of IBD natural diet modalities at 
baseline (Phase I) and follow-up (Phase III). At baseline, 45.5% of fellows reported that IBD 
natural diet modalities were ‘optional treatment options available to patients,’ while 36.4% said 
natural diet modalities were ‘not well studied/unsure,’ and only 18.2% reported they were 
‘standard of care.’ Change in participants’ knowledge of the utilization of natural diet modalities 
in IBD was not statistically significant; however, descriptively more fellows recognized IBD 
natural diet modalities were ‘standard of care,’ while no fellows reported ‘not well studied/unsure’ 
at follow-up.  
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Table 3. Fellows’ Knowledge of Utilization of Natural Diet Modalities in IBD from Baseline (Phase I) to 
Follow-up (Phase 3) 
 Phase I Phase III  p-value 
Question  % (n) % (n)  




Standard of care 18.38% (2) 41.7% (5) 
Optional treatment options available to patients 45.6% (5) 58.3% (7) 
Not well studied/unsure 36.4% (4) 0% (0) 
NOTE: McNemar-Bowker test was used to test whether there was a significant difference in participants’ 
choice of the options before and after the intervention.  
 
Table 4 includes fellows’ knowledge of the benefits of IBD natural diet modalities from 
baseline (Phase I) to follow-up (Phase III). At baseline, 30% of fellows reported that natural diet 
modalities in IBD ‘can improve signs and symptoms of IBD’ and ‘can reduce and help control 
episodes of flare-ups,’ while 20% said natural diet modalities ‘can reduce disease complications 
such as ED visits, disease progression, etc.,’ 16.7% reported they were ‘unsure,’ and 3.3% reported 
‘none of the above.’ Descriptively, more fellows recognized IBD natural diet modalities can 
improve the disease, while 0% of fellows were ‘unsure’ or checked ‘none of the above’ at follow-
up. A McNemar test was used to compare whether each participant’s probability of selecting ‘none 
of the above’ had changed after the intervention. It was shown that participants’ knowledge of the 
natural diet modalities changed significantly (p = 0.04).  
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Table 4. Fellows’ Knowledge of Benefits of Natural Diet Modalities in IBD at Baseline (Phase 1) to Follow-up 
(Phase 3) 
 Phase I  Phase III p-value 
                                   Question % (n) % (n)   
Which of the following are benefits of natural diet modalities in IBD? (Choose all that apply):  
 
 
   
0.04123 
Can improve signs and symptoms of IBD 30% (9) 34.9% (15) 
Can reduce and help control episodes of flare ups 30% (9) 32.6% (14) 
Can reduce disease complications (e.g., ED visits, disease progression) 20% (6) 32.6% (14) 
I am unsure 16.7% (5) 0% (0) 
None of the above 3.3% (1) 0% (0) 
NOTE: McNemar test was used to test whether the probability of selecting ‘none of the above’ or ‘I am unsure’ 
has changed after intervention. 
 
Table 5 includes the results comparing fellows’ knowledge of IBD diets from baseline 
(Phase I) to follow-up (Phase III). At baseline, 91.3%  of fellows selected at least one correct 
example of an IBD diet, while 8.3% said they ‘never heard of natural diet modalities’ and at least 
2.3% of respondents reported ‘none of the above.’ At follow-up, all fellows recognized the 
majority of IBD diets and none reported ‘none of the above’ or said they ‘never heard of the use 
of natural diet modalities in IBD disease management.’ The McNemar test comparing pre- and 
post-intervention difference in participants’ selection of ‘I am unsure’ and/or ‘none of the above’ 
was not statistically significant (p = 0.1336).   
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Table 5. Fellows’ Knowledge of IBD Diets at Baseline (Phase I) to Follow-up (Phase III). 
Question % (n) % (n) p-value   
Which of the following are examples of IBD diets? (Choose all that apply):  
0.1336 
Carbohydrate Exclusion Diet 13.9% (5) 13.8% (13) 
Mediterranean Diet 2.8% (1) 12.77% (12) 
Anti-inflammatory Diet 19.4% (7) 16.0% (15) 
Low Fiber Diet 8.33% (3) 11.7% (11) 
Low FODMAP Diet 25% (9) 13.8% (13) 
Gluten-Free Diet 13.9% (5) 9.6% (9) 
Elimination Diet 5.6% (2) 12.8% (12) 
Maker’s Diet 0% (0) 9.6% (9) 
None of the above 2.8% (1) 0% (0) 
Unsure  8.3% (3) 0% (0) 
NOTE: McNemar test was used to test whether the probability of selecting ‘none of the above’ or ‘unsure’ has 
changed after intervention. 
3.4 Comparing Fellows’ Behavior from Baseline to Follow-up  
The majority of fellows reported seeing 1-10 IBD patients at both time points (baseline: 
56.3%; follow-up: 50%) while 31.2% of fellows said they saw 11-20 patients at follow-up (Phase 
III), a 12.5% increase from baseline. However, the Wilcoxon signed-rank tests revealed there was 
no significant change in the number of IBD patients each fellow had seen in the past month (p-
value=0.1817) (Table 6).   
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Table 6. Number of IBD Patients Seen at Baseline (Phase I) and Follow-up (Phase 3) 





                                                       % (n) % (n) 
In the past month (30 days), how many IBD patients have you seen? 
0 12.5% (2) 6.2% (1) 
1-10 56.2% (9) 50% (8) 
11-20 18.7% (3) 31.2% (5) 
21-50 12.5% (2) 6.2% (1) 
51-70 0% (0) 6.25% (1) 
NOTE: Wilcoxon signed-rank tests was used for paired comparisons.  
 
Figure 5 includes the frequency of fellows’ consults with outpatient dietary services at 
baseline (Phase I) and follow-up (Phase III). According to the results of the Wilcoxon signed rank 
test, there was not a statistically significant difference in participants’ frequency of consulting with 
outpatient dietary services at the DDC from baseline to follow-up (p = 1.00). 
 
 
Figure 5. Frequency of Fellows’ Consults with Outpatient Dietary Services at Baseline (Phase I) and Follow-









Q13 Before Q13 After
How often do you consult with outpatient dietary services at the 
DDC?
Never Rarely Sometimes Often
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To build on these results, Table 7 includes the number of IBD patient referral rates to 
outpatient dietary services at baseline (Phase I) and follow-up (Phase III). At baseline, 78.6% of 
fellows reported that they referred zero IBD patients to outpatient dietary services and 21.4% 
reported referring 1-2 patients. At follow-up, 53.3% said they referred zero patients, 26.7% of 
fellows referred 1-2 patients, and 20% referred 3-5 patients. The results of the Wilcoxon signed-
rank test reported a trend toward significance in the number of IBD patients referred to outpatient 
dietary services after the intervention (p = 0.0969). We can appreciate the descriptive difference 
in referral rates shown in Figure 6. 
 
Table 7. Fellows’ IBD Patient Referral Rates to Outpatient Dietary Services in the Past Month at Baseline 
(Phase 1) to Follow-up (Phase 3). 






% (n) % (n)  
In the past month (30 days), how many of those patients did you refer to outpatient dietary 
services? 
 
0 78.6% (11) 53.3% (8)  
1-2 21.4% (3) 26.7% (4)  
3-5 0% (0) 20% (3)  
6-8 0% (0) 0% (0)  
9-11 0% (0) 0% (0)  
12+ 0% (0) 0% (0)  
Note: Wilcoxon signed-rank tests was used for paired comparisons.  
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Figure 6. Fellow’s IBD Patient Referral Rates to Outpatient Dietary Services in the Past Month at Baseline 
(Phase I) and Follow-up (Phase III). 
 
Table 8 includes the results of the frequency with which fellows’ spoke with their IBD 
patients about natural diet modalities at baseline (Phase I) and follow-up (Phase III). At baseline, 
50% of fellows reported that they ‘never’ talked to patients about natural diet modalities, 37.5% 
reported ‘rarely,’ and 12.5% reported ‘sometimes.’ None of the fellows reported that they ‘always’ 
talked to patients about natural diet modalities. At follow-up, only 25% said they ‘never’ talked to 
IBD patients about natural diet modalities, while 37.5% reported talking to patients ‘rarely’ and 
‘sometimes.’ Wilcoxon signed rank test showed that the difference in the frequency of talking to 








Q8 Before Q8 After
In the past month (30 days), how many of those patients 








Table 8. Frequency of Fellows Speaking with IBD Patients About Natural Diet Modalities at Baseline 
 (Phase 1) and Follow-up (Phase 3). 




                                                                  % (n)                           % (n)  
In the past month (30 days), how often have you talked with your patients about natural diet 
modalities to help to control the signs and symptoms of the disease? 
Never 50% (8) 25% (4) 
Rarely 37.5% (6) 37.5% (6) 
Sometimes 12.5% (2) 37.5% (6) 
Always 0% (0) 0% (0) 
Note: Wilcoxon signed-rank tests was used for paired comparisons.  
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4.0 Section 4:  Learning & Actions  
4.1 Discussion 
My problem of practice is that the gastroenterology practitioners at the DDC underutilize 
nutritional services to manage the symptomology of the disease. Currently, our gastroenterology 
clinics operate without the use of dietary services to care for Crohn’s and ulcerative colitis patients 
although both patients and practitioners could greatly benefit from the use of nutritional services 
at the DDC. In my inquiry, I sought to investigate if educating gastroenterology fellows about the 
role of IBD diets in IBD management could increase nutrition knowledge and improve the referral 
rate to nutritional counseling. My intervention was grounded in the literature that purports that 
improving physician practices and increasing patient health outcomes can be achieved through 
providing educational opportunities to practicing physicians (Davis, 1995). A good example of 
such intervention would be the study on hand hygiene among physicians, and its compliance 
outcomes in hospital settings. The 2019 study by Shim et al. found that staff, fellow, and resident 
compliance with handwashing was greater if the instructions or if the initiative originated from the 
teaching or leadership hierarchy. This current inquiry suggested that leadership influence and 
fellowship training could be an effective method of shaping new or recommended practices among 
GI fellows.  
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4.1.1 Inquiry Question 1  
There were three primary inquiry questions that guided my investigation. First, I aimed to 
assess fellows’ current referral rate of IBD patients to nutritional services and determine whether 
this practice changed following participation in the education module. My study demonstrated no 
significant change in the number of patients each participant referred to outpatient dietary services 
following the education module. However, there were descriptive differences, with more fellows 
reporting they referred 3-5 IBD patients to outpatient nutrition. Moreover, the overwhelming 
majority of fellows reported immediately after participating in the module that they planned to 
refer more patients. It is possible that I was unable to observe their intentions translate into 
behavior change during this brief follow-up period (30 days). As in the case of Reyna’s “Theories 
of Medical Decision Making and Health: An Evidence-based Approach, ”attitudes about the 
“retrieval values” of a particular action often rely on approval of others, and the new behavior 
takes time to form. In this case, the reasons why physicians generally do not refer eligible patients 
to outpatient dietary support might be partially rooted in the perception of limited value and 
personal perception. In other words, patients and providers often mirror each other’s perception of 
the risks and benefits of a given action or intervention if they both lack with familiarity about the 
subject.  I expect more time with additional prompts/reminders would lead to a change in behavior 
following this education module.   
Although I failed to see a statistically significant increase in the number of IBD patients 
that the fellows referred to outpatient in the last 30 days before and after the intervention, I did see 
a trend toward increasing these numbers, which may suggest clinical significance. Further, I only 
provided a one-time, self-paced educational intervention in this study. In the future, weekly email 
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reminders/prompts following the module could be provided to potentially enhance the intervention 
effect and improve the referral rate.  
4.1.2 Inquiry Question 2 
The second inquiry question sought to assess the fellows’ current knowledge base 
regarding IBD diets and DDC nutritional services and whether it changed following participation 
in the education module. The results demonstrated that the participants’ knowledge of the natural 
diet modalities improved significantly following the education module, providing initial evidence 
for the effectiveness of the brief intervention. This is a considerable success of this short, cost 
effective intervention, since more practitioners recognized IBD diets as evidenced in the post 
intervention test scores. Previous studies attempting to improve professional skill and knowledge 
base among medical professionals noted the constant need to deliver evidence-based practice and 
quality improvement approaches in health settings. According to Worsley et al. (2016), 
improvement should be an integral and continuous process for all medical professionals, a 
workplace habit and culture of refinement in healthcare systems. In this case, improving 
knowledge of fellows empowers both practitioners and the patients, and it may result in benefits 
to all stakeholders. Currently, the primary model of care in IBD patients delivers fragmented 
support where diets or natural modalities are rarely discussed (Regueiro, 2017).  Drawing upon 
expertise of DDC nutritionists in care of IBD patients, this inquiry lays the important groundwork 
for changing the current system/paradigm of care. 
Similarly, the study demonstrated that participants’ familiarity with outpatient dietary 
services has significantly improved after participating in the online module. The study raised 
important awareness about the role of diet in IBD, and coupled with culture change and support 
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from physicians, this could spark a shift in the how care is delivered at the DDC to IBD patients 
in the future. We can observe that post data clearly demonstrates that fellows are now more likely 
to recognize the role of diet in IBD and more likely to advocate and recommend dietary counseling.  
4.1.3 Inquiry Question 3 
The third and final question in this inquiry sought to investigate how often GI fellows spoke 
with patients about natural diet modalities and whether this occurrence increased following 
participation in the education module. Fellows’ frequency of consulting with outpatient dietary 
services at the DDC did not significantly change following the intervention. This could be 
attributed to the limited time that fellows had to modify their behavior in the post intervention 
period, since the question asked specifically about their referral patterns in the last 30 days. Also, 
it is possible that actual referral rates may differ from self-reported referral rates. According to 
Gardner’s (2012) science of habit formation, whether it is the patient or the physician, bringing up 
behavior change such as dietary modification is not without risk, as it could affect the patient–
doctor relationship. As it turns out, the psychology of habit formation and general practice 
especially when it pertains to lifestyle changes in patients, requires time and trust, and take a 
special process to implement (Gardner, 20121).   
I saw descriptive improvements in the frequency of fellows speaking with patients about 
natural diet modalities. Fewer fellows reported ‘never’ and more reported ‘sometimes’ at follow-
up; however, no fellows reported ‘often.’ Because this was only a single intervention introduced 
into the system, future PDSA cycles will likely take additional system-level interventions to make 
a true culture change. Additionally, this study did not explore potential barriers and facilitators of 
the electronic patient referral management system at UPMC, the established models for patient or 
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professional reimbursement, possible insurance barriers, or patient access to ancillary care. Future 
studies need to determine which factors affect how often GI fellows are willing to initiate referral 
discussions with patients.  
4.1.4 Theory of Improvement and Future PDSA Cycles 
Current findings suggest that system change produced improvements in some aspects, but 
failed to increase the current referral rates and was unable to fully shift the current system during 
this PDSA cycle.  These findings confirm that a system change is a very complex process that 
takes several cycles to shift the system and requires constant adjustments and revisiting of the 
study measures. Future PDSA cycles should extend the follow-up period and provide periodic 
encouragement to help reinforce the intended behavior change among GI fellows. On the other 
hand, the education module has affected the primary and secondary drivers as knowledge base of 
GI fellows significantly changed following the intervention, which will shift the system moving 
forward.  My predictions  for the inquiry and future analysis are that the module will orient future 
GI cohorts to produce the desired behavior over time and serve as a benchmark for long term 
change, which is tied to my aim statement.   
4.1.5 Strengths and Weaknesses 
Noted strengths of the study include the brief, online, self-paced education module. The 
training was welcomed and highly rated by fellows, as it was effective in introducing new 
treatment options for IBD patients. Although the module was relatively succinct and compressed 
in nature, it generated significant interest and appreciation for the topic. It also resulted in requests 
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for additional information from fellows and with one suggestion to implement this training into 
their standard training curriculum. This inquiry confirmed that standard medical school curricula 
are void of nutritional science courses and/or likely underpreparing future physicians to counsel 
patients on the role of nutrition in chronic disease.  
The project also highlighted some weaknesses that could be targeted as next steps for 
research. I can speculate that the fellows did not have sufficient opportunities to see a significant 
number of patients, as some of the providers actually reported seeing fewer patients for unknown 
reasons following the education module.  It is likely that the follow-up period was relatively short 
in duration to see sustained change. I would recommend allowing more time for follow-up in the 
future intervention (not just 30 days, as in this case), extending the timeline to possibly several 
months, and providing periodic encouragement and reminders from leadership to bolster support 
and to improve behavior (Davis, 1995).  
Additionally, one major limitation of this study is the small sample size. Although I 
included majority of participants from the Gastroenterology Fellowship Program at UPMC, there 
were a few participants from the 1st year who did not take part with only have 16 out of 19 
participants in total. This would lead to limited power in detecting intervention effect and may fail 
to capture the intervention effect in some aspects. In the analysis of the “select all that apply” 
questions, the McNemar test was used, but other tests may have provided different results. As 
such, caution is needed when interpreting the results of these questions.  
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4.2 Next steps and Implications 
The education module developed for this inquiry could be improved upon based on 
fellows’ feedback and integrated into the local IBD curriculum as it offers an inexpensive option 
to supplement the existing GI training program outside of the surgical and pharmacological 
applications. The educational tool could be easily utilized for onboarding future cohorts of GI 
fellows to familiarize them with IBD diets and dietary services at the DDC in their first year of 
training. Additionally, we should follow-up with the fellows over their time in the program to 
support them in this change.   
As for implications for practice, my next important step will be to work with IBD patients 
and nutritionists to develop patient materials to empower patients to work with their physicians for 
better outcomes. If fellows are more willing to have conversations and refer patients, this might 
also result in increased interest among patients; however, we must remember that it is a two-way 
street. Patients who are interested in exploring natural diet modalities or are ready to make diet 
changes can raise the discussion with their doctors. A brochure with information about the DDC 
nutritionists, services, and potential diet options, as well as current research in the field, could 
potentially encourage direct patient-doctor discussions.  These materials could prompt patients to 
have conversations with their doctor, and if the providers are already equipped with this 
knowledge, this could also lead to more referrals. With a brochure, the DDC could facilitate the 
referral process without necessitating more consultation time during regular doctor visits in the 
office.  
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5.0 Reflections  
5.1 Reflections on the Improvement Process 
 Working in the field of healthcare as a research coordinator, I have observed that best 
practices and improved patient outcomes are most often attainable over time via the ambitious and 
relentless attempts to improve patient and physician knowledge base. Things always look easier 
on the outside, but this is not the case in the improvement process. The science of improvement 
within the healthcare system poses unique challenges as it involves a strata of departments and 
individuals that are constantly involved in a mutual interplay of governing bodies, policies, health 
care regulatory standards, and other regulatory elements. In other words, change in healthcare is 
never easy or quick and this was very evident in my own pursuit of this project as well.   
Luckily for me, the concept of nutritional support in the management of chronic diseases 
is not entirely foreign in traditional medicine; however, its value has been greatly underestimated 
in the case of IBD. Both patients and physicians are best empowered when the so-called elephant 
in the room is acknowledged: in this case, this chronic disease stems from inflammation in the gut 
and yet the role of nutrition in the management is rarely discussed by either the doctor or the 
patient. If there are significant deficits in either party’s knowledge about potential for alternative 
treatments that should be approached with care and a transparent desire to accommodate the 
patient’s needs in the clinical settings. Knowledge of prescribed treatment options is especially 
limited (and expected) in patients; if the lack of education is rooted in the medical system itself, 
then patients might lose trust and confidence in their physicians.  
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My strong desire to make a difference and offer alternative solutions to the struggling 
patients and the hardworking physicians via simply educating all stakeholders on the treatment 
options has motivated my actions from before my first semester in the EdD program. I believe in 
integrating the best elements of traditional and alternative medicine (i.e., integrative medicine) and 
I wanted to make my own imprint at the DDC by promoting it via fellow education within my 
department. As per a recently published meta-analysis study, integrative medicine is the future of 
medicine as more and more patients and medical schools look to integrate traditional medicine 
with natural therapies (Grant, 2014).          
In my own journey of designing and promoting this improvement science project, I have 
learned a lot. First, that one needs to break down and analyze all aspects of the problem through 
an “all inclusive” lens in order to formulate a solution that is free of bias, such as personal 
experiences or beliefs about the problem. Elements such as analytic skills, resourcefulness, grasp 
of system theories, understanding of clinical practice and science, as well as statistics and other 
fields, all play an important role in generating a plan and results for the improvement of healthcare 
delivery (Institute for Healthcare Improvement: Science of Improvement, 2021). I have further 
realized the importance of impassioning other key players in the process. I have experienced first-
hand issues with attaining full participation of the fellows. My subject pool was limited to a finite 
number of individuals within the GI fellowship program and I ran into issues of limited 
participation, even with the support of the department head and the director of the fellowship 
program. Working in the field of clinical research, I have personally experienced daily challenges 
with the implementation process. However, this time, I grew a greater appreciation for those who 
struggle to develop a road map for any system-level change within an organization. I think that I 
anticipated many hurdles, hassles, and roadblocks; however, I now have a new appreciation for 
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those who design and conceptualize studies and solutions, as my professional role so far has been 
limited to executing/coordinating such projects.  
My main takeaway is that analytical thinking and skills, creativity, and process planning 
are key, but also challenges in the improvement process. I have also recognized that buy-in from 
the stakeholders is invaluable. A proposal cannot move forward no matter how important or big 
unless it has the support of the key players at all levels of the organization. According to a 2015 
Forbes article “70% of all organizational change efforts fail” and the reason for failure can be 
attributed to the fact that its execution did not win enough hearts or minds of the key movers 
(Hedges, 2015 p 1.) . I am reminded yet again that without my own determination, hard work, and 
personal and professional commitment to the process, combined with the kind professional support 
and invaluable mentoring from others more senior and accomplished in the field, I would have 
been unable to arrive to this point.  
The process of improvement, whether in science or personal life, is an iterative process 
with endless opportunities for improvement and fortunately or unfortunately, we are never allowed 
to give up. We can begin on a small scale to try out a change idea, assess the early results, and 
revise the change if needed. If satisfied with the progress, we settle to implement the change 
locally, expand the change, or scale-up. As leaders and scholar practitioners, we will likely never 
stop this process as we are set up to learn from our successes as well as our failures. This is what 
I will personally apply in my own professional journey to other problems of practice moving 
forward. 
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Appendix A Driver Diagram.  
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Appendix B Fishbone Diagram. 
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Appendix C Phase I (Recruitment Letter). 
Dear DOM Gastroenterology Fellow, 
I am a doctoral student in the University of Pittsburgh’s Health and Physical Activity EdD 
Program. I am currently conducting an inquiry project as part of my doctoral dissertation work to 
gain a better understanding of GI fellows’ knowledge of natural diet modalities in IBD and current 
patient referral rates to nutritional services. You have been chosen to participate in this study 
because you are a 1st, 2nd, 3rd, or 4th year Department of Medicine Gastroenterology Fellow.  
The study will occur in 4 Phases. In Phase  I (Week 1/Day 1), you will be asked to complete 
a baseline assessment via an online survey management platform called Qualtrics that will take no 
more than ten minutes to complete. You will be assigned an ID number and all of your survey 
responses will be kept anonymous. Following completion of this baseline survey, in Phase II 
(Week 1/Day 1), you will be asked to view a brief education module that discusses the current 
literature and diet options in IBD, as well as provides information on nutritional services at the 
DDC. In the Phase III of the study, also on the same day, you will be asked to complete a post 
module assessment questionnaire. The total time for the study should not be more than 45 minutes. 
In the final phase of the study, Phase IV (Week 4/Day 1), you will complete one final short survey 
at the end of the study.  
There are no direct benefits for participation in this study, nor is there any compensation. 
Your participation in this study is entirely voluntary and you can stop at any time.  
Should you wish to receive results of the study, you may request a copy be emailing me at 
bbp10@pitt.edu. The study data will only be available to me as the researcher, as well as my 
Doctoral Advisor and Committee Chair, Dr. Sharon Ross. If you have questions or concerns about 
the study, you can also contact Dr. Ross at seross@pitt.edu for additional information.  




Health and Physical Activity EdD Doctoral Candidate 
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Appendix D Appendix D. Phase I (Baseline Assessment Survey) 
 Gastroenterology Fellow Natural Diet Modalities Knowledge  
 
Thank you for taking the time to participate in this short survey to assess your knowledge 
about natural diet modalities in IBD and nutritional services at the DDC.  
 
Q1. What year in fellowship program are you? 
o1st 
o2nd 
o3rd   
o4th 
Q2. What are your fellowship specialty interests?  
oIBD  
oLiver   
oPancreatobiliary  
oGeneral GI 
oOther (Please specify: ..)  
Q3. According to the American Gastroenterology Association (AGA), natural diet 
modalities in IBD are… 
(Check all that apply): 
71 
oStandard of care   
oOptional treatment options available to patients  
oHave not been well studied   
oThere are no AGA recommendations related to natural diet modalities 
oUnsure 
 
Q4. Which of the following are benefits of natural diet modalities in IBD? (Choose all 
that apply): 
▢   Can improve  signs and symptoms of IBD   
▢   Can reduce and help control episodes of flare ups  
▢   Can reduce disease complications (e.g., ED visits, disease progression) 
▢   I am unsure 
▢   None of the above  
▢   All of the above  
 
Q5. Which of the following are examples of IBD diets? (Choose all that apply): 
 
▢   Carbohydrate Exclusion Diet  
▢   Mediterranean Diet  
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▢  Anti-inflammatory Diet  
▢  Low Fiber Diet 
▢  Low FODMAP diet 
▢  Gluten-Free Diet 
▢  Elimination Diet 
▢  Maker’s Diet 
▢  All of the above  
▢  None of the above 
▢  I never heard of the use of natural diet modalities in IBD disease management 
 
Q6. Which of the following patients meet criteria for outpatient nutrition referral? 
(Choose all that apply): 
▢  Crohn’s disease   
▢  Ulcerative colitis  
▢  Other unspecified GI 
▢   Nutritional deficiencies/malnutrition  




 Q7. In the past month (30 days), how many IBD patients have you seen?  
o1-10  
o11-20   
o20-50  
o50-70 
oOther (Please specify: ..)  
 
Q8. .  In the past month (30 days), how many of those patients did you refer to 
outpatient dietary services?    
o  0 
o 1-2 




o  Other (Please specify:..) 
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Q9. In the past month (30 days), how often have you talked with your patients about 






Q10. Have you ever taken nutrition course that covered the importance of the role of 
natural diet modalities in disease management in either medical school or anytime during 
your GI fellowship training? 
oYes  (please specify): 








oOther (Please specify):  
 
Q12. How familiar are you with outpatient dietary services at the DDC?  
oVery Familiar   
oSomewhat familiar 
oNot familiar   
 
Q13. How often do you consult with outpatient dietary services at the DDC?  

























Appendix F Phase III. (Post Module Assessment: Knowledge) 
After completing the education module, please answer the following questions below 
about your current IBD knowledge:  
 
Q1. According to the American Gastroenterology Association (AGA), natural diet 
modalities in IBD are…(Check all that apply):  
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oStandard of care   
oOptional treatment options available to patients  
oHave not been well studied   
oThere are no AGA recommendations related to natural diet modalities 
oUnsure 
 
Q2. Which of the following are benefits of natural diet modalities in IBD? (Choose all 
that apply): 
▢    Can improve  signs and symptoms of IBD   
▢  Can reduce and help control episodes of flare ups  
▢  Can reduce disease complications (e.g., ED visits, disease progression) 
▢    I am unsure 
▢  None of the above  
▢  All of the above 
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Q3. Which of the following are examples of IBD diets? (Choose all that apply): 
 
▢   Carbohydrate Exclusion Diet  
▢   Mediterranean Diet  
▢  Anti-inflammatory Diet  
▢  Low Fiber Diet 
▢  Low FODMAP diet 
▢  Gluten-Free Diet 
▢  Elimination Diet 
▢  Maker’s Diet 
▢  All of the above 
▢  None of the above   
▢   I never heard of the use of natural diet modalities in IBD disease management 
 
Q4. Which of the following patients meet criteria for outpatient nutrition referral? 
(Choose all that apply): 
▢    Crohn’s disease   
▢  Ulcerative colitis  
▢  Other unspecified GI 
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▢   Nutritional deficiencies/malnutrition  
▢   Other (Please specify:..) 
Q5. Which of the following patients meet criteria for outpatient nutrition referral? 
(Choose all that apply) 
▢    Crohn’s disease   
▢  Ulcerative colitis  
▢  Other unspecified GI 
▢   Nutritional deficiencies/malnutrition  
▢  Other (Please specify:…) 
 
Q6. How familiar are you with outpatient dietary services at the DDC?  
oVery Familiar   
oSomewhat familiar 
oNot familiar   
 
Q7. After reviewing the module, do you plan to refer more patients to outpatient 
nutrition services? 
oYes   




Q8. How effective was the education module at increasing your IBD knowledge of 
natural diet modalities?  
 
oVery effective   
oSomehow effective    
oNot effective  
oOther (Please specify): 
 
 
Q9. What was the most important information you learned? (text write in) 
 
Q10. How do you plan to use the information on natural diet modalities in IBD? 
 




Appendix G. Phase IV. (Post Module Assessment: Behavior).  
 
Q1. In the past month (30 days), how many IBD patients have you seen?  
o1-10  
o11-20   
o20-50  
o50-70 
oOther (Please specify: ..)  
 
Q2.  In the past month (30 days), how many of those patients did you refer to 
outpatient dietary services?   
o 0 
o 1-2 




o Other (Please specify:..) 
 
Q3. In the past month (30 days), how often have you talked with those patients 
about natural diet modalities to help to control the signs and symptoms of the disease?  
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Q4. How often did you consult with outpatient dietary services at the DDC?  




oNot familiar   
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